ZA896231B - Heparin fragments and fractions with anti-hiv action - Google Patents
Heparin fragments and fractions with anti-hiv actionInfo
- Publication number
- ZA896231B ZA896231B ZA896231A ZA896231A ZA896231B ZA 896231 B ZA896231 B ZA 896231B ZA 896231 A ZA896231 A ZA 896231A ZA 896231 A ZA896231 A ZA 896231A ZA 896231 B ZA896231 B ZA 896231B
- Authority
- ZA
- South Africa
- Prior art keywords
- fractions
- heparin fragments
- hiv action
- hiv
- action
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
- C08B37/0078—Degradation products
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL8802087 | 1988-08-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA896231B true ZA896231B (en) | 1990-05-30 |
Family
ID=19852794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA896231A ZA896231B (en) | 1988-08-24 | 1989-08-15 | Heparin fragments and fractions with anti-hiv action |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0355905B1 (de) |
JP (1) | JPH02108624A (de) |
KR (1) | KR0143084B1 (de) |
AT (1) | ATE84217T1 (de) |
AU (1) | AU617850B2 (de) |
CA (1) | CA1330305C (de) |
DE (1) | DE68904264T2 (de) |
DK (1) | DK416089A (de) |
ES (1) | ES2053953T3 (de) |
IE (1) | IE61565B1 (de) |
NZ (1) | NZ230394A (de) |
PT (1) | PT91524B (de) |
ZA (1) | ZA896231B (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08109134A (ja) * | 1994-10-11 | 1996-04-30 | Sanwa Kagaku Kenkyusho Co Ltd | 細胞変成抑制並びに臓器毒性軽減剤 |
US5763427A (en) * | 1995-03-31 | 1998-06-09 | Hamilton Civic Hospitals Research Development Inc. | Compositions and methods for inhibiting thrombogenesis |
EP0735050B1 (de) * | 1995-03-31 | 2002-09-25 | Hamilton Civic Hospitals Research Development, Inc. | Zusammensetzung zur Hemmung der Thromboseentstehung |
US6001820A (en) * | 1995-03-31 | 1999-12-14 | Hamilton Civic Hospitals Research Development Inc. | Compositions and methods for inhibiting thrombogenesis |
US5744457A (en) * | 1995-03-31 | 1998-04-28 | Hamilton Civic Hospitals Research Development Inc. | Compositions and methods for inhibiting thrombogenesis |
US5767269A (en) * | 1996-10-01 | 1998-06-16 | Hamilton Civic Hospitals Research Development Inc. | Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics |
DE19836339B4 (de) | 1998-08-11 | 2011-12-22 | N.V. Nutricia | Kohlenhydratmischung |
ATE358486T1 (de) * | 2000-11-09 | 2007-04-15 | Contrimmune Biotechnology Inc | Verwendung von xestospongin c zur behandlung oder vorbeugung einer hiv-infektion |
FR2838649B1 (fr) * | 2002-04-19 | 2006-01-13 | Commissariat Energie Atomique | Composition anti-vih, procede de fabrication et medicament |
US20040229778A1 (en) * | 2003-05-13 | 2004-11-18 | Elmaleh David R. | Pharmaceutical compositions of antithrombin III for the treatment of retroviral diseases |
EP1597978A1 (de) | 2004-05-17 | 2005-11-23 | Nutricia N.V. | Synergie von GOS und polyfruktose |
US8252769B2 (en) | 2004-06-22 | 2012-08-28 | N. V. Nutricia | Intestinal barrier integrity |
EP1721611A1 (de) * | 2005-04-21 | 2006-11-15 | N.V. Nutricia | Nahrungsergänzungspräparat mit Oligosacchariden für eine Kategorie von HIV Patienten |
US8845026B2 (en) | 2009-07-03 | 2014-09-30 | Ts Tech Co., Ltd. | Vehicle seat |
KR20130045385A (ko) | 2010-09-14 | 2013-05-03 | 에프. 호프만-라 로슈 아게 | 세르핀-핑거 융합 폴리펩티드 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3422518A1 (de) * | 1984-06-16 | 1985-12-19 | B. Braun Melsungen Ag, 3508 Melsungen | Heparin-derivate, verfahren zu ihrer herstellung, diese enthaltende arzneimittel und ihre verwendung bei der behandlung von fettstoffwechselstoerungen |
NZ222695A (en) * | 1986-11-29 | 1990-03-27 | Ueno Seiyaku Oyo Kenkyujo Kk | Synergistic antiviral compositions |
WO1990003791A1 (en) * | 1988-10-05 | 1990-04-19 | Nicola Diferrante | Methods for interfering with hiv multiplication and composition for the treatment of aids |
-
1989
- 1989-08-09 DE DE8989202061T patent/DE68904264T2/de not_active Expired - Fee Related
- 1989-08-09 IE IE256589A patent/IE61565B1/en not_active IP Right Cessation
- 1989-08-09 EP EP89202061A patent/EP0355905B1/de not_active Expired - Lifetime
- 1989-08-09 AT AT89202061T patent/ATE84217T1/de not_active IP Right Cessation
- 1989-08-09 ES ES89202061T patent/ES2053953T3/es not_active Expired - Lifetime
- 1989-08-15 ZA ZA896231A patent/ZA896231B/xx unknown
- 1989-08-17 AU AU40012/89A patent/AU617850B2/en not_active Ceased
- 1989-08-21 KR KR1019890011856A patent/KR0143084B1/ko not_active IP Right Cessation
- 1989-08-22 NZ NZ230394A patent/NZ230394A/en unknown
- 1989-08-23 DK DK416089A patent/DK416089A/da not_active Application Discontinuation
- 1989-08-23 PT PT91524A patent/PT91524B/pt not_active IP Right Cessation
- 1989-08-23 CA CA000609119A patent/CA1330305C/en not_active Expired - Fee Related
- 1989-08-23 JP JP1217165A patent/JPH02108624A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
KR0143084B1 (ko) | 1998-07-15 |
CA1330305C (en) | 1994-06-21 |
ES2053953T3 (es) | 1994-08-01 |
DE68904264D1 (de) | 1993-02-18 |
DK416089D0 (da) | 1989-08-23 |
AU617850B2 (en) | 1991-12-05 |
DK416089A (da) | 1990-02-25 |
EP0355905B1 (de) | 1993-01-07 |
IE892565L (en) | 1990-02-24 |
KR900002788A (ko) | 1990-03-23 |
AU4001289A (en) | 1990-03-01 |
IE61565B1 (en) | 1994-11-16 |
DE68904264T2 (de) | 1993-05-27 |
NZ230394A (en) | 1997-02-24 |
ATE84217T1 (de) | 1993-01-15 |
PT91524A (pt) | 1990-03-08 |
JPH02108624A (ja) | 1990-04-20 |
PT91524B (pt) | 1995-07-18 |
EP0355905A1 (de) | 1990-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA896231B (en) | Heparin fragments and fractions with anti-hiv action | |
EP0293826A3 (de) | Therapeutische und prophylaktische Gabe von sulfatierten Polysacchariden gegen AIDS | |
AU1935788A (en) | A process for producing an administration and/or dosage form for medically active ingredients of drugs | |
HK55896A (en) | Pharmaceutical composition comprising 3'-deoxythymidin-2'-ene (3'-deoxy-2' 3'-didehydrothymidine) in treating patients infected with retrovirus | |
ZA885577B (en) | A pharmaceutical combination product and the preparation and use thereof | |
ES2026304A6 (es) | Procedimiento de fabricacion de una forma de dosificacion de nicardipina. | |
EP0311107A3 (de) | Anti-HIV-aktive 3'-Fluoro-purin-2',3'-dideoxyriboside | |
GR3005927T3 (de) | ||
AU5038990A (en) | Anti-hiv drug | |
EP0325768A3 (en) | Non-reverting rna viruses | |
IE892654L (en) | Therapeutic nucleosides | |
AU2880595A (en) | Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses | |
AU3852989A (en) | Method of inhibiting the activity of human immunodeficiency virus (hiv) in vivo | |
IL81568A0 (en) | Plasmids which inhibit human t-cell lymphotropic virus type iii replication | |
NO965556L (no) | Trippelkombinasjon mot HIV | |
WO1990005523A3 (en) | Phenanthrolinedicarboxylate esters, 4-aminoquinoline and isoquinoline derivatives as inhibitors of hiv reverse transcriptase | |
AU7512287A (en) | Expression of human t-cell lymphotropic virus (htlv-iii)reve rse transcriptase and uses thereof | |
EP0311108A3 (de) | Anti-HIV-aktive 3'-Azido-2,6-diaminopurine-2',3'-dideoxyriboside | |
EP0316592A3 (de) | 3'-Fluor-2',3'-dideoxyuridin und seine therapeutische Verwendung | |
EP0308977A3 (en) | Anthracycline derivatives having inhibitory activity against reverse transcriptase of human immunodeficiency virus | |
IL144382A0 (en) | HIV-1 MUTATIONS SELECTED FOR BY β-2',3'-DIDEHYDRO-2',3-DIDEOXY-5-FLUROCYTIDINE | |
AU630099B2 (en) | Non-reverting rna viruses | |
AU2065488A (en) | The preparation of antigens of human immunodeficiency virus type 1, and the use thereof as diagnostic and therapeutic agent | |
AU2880495A (en) | Use of pharmaceutical agents for alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses | |
WO1988008707A3 (en) | Rubradirin derivatives for treatment of hiv infection |